HOME >> MEDICINE >> NEWS
MR spectroscopy significantly reduces need for breast biopsy

OAK BROOK, Ill.--In a study featured in the June issue of Radiology, researchers found that imaging suspicious breast lesions with magnetic resonance (MR) spectroscopy reduced the need for biopsy by 58 percent. The investigators, from Memorial Sloan-Kettering Cancer Center in New York, discovered that with the addition of MR spectroscopy to their breast MR imaging (MRI) protocol, 23 of 40 suspicious lesions could have been spared biopsy, and none of the resultant cancers would have been missed.

"All cancers in this study were identified with MR spectroscopy. There were no false-negative results," said Lia Bartella, M.D., lead investigator and assistant professor in the Department of Breast Imaging at Memorial Sloan-Kettering. "With the addition of MR spectroscopy to our breast MRI exam, we found that the number of biopsies recommended on the basis of MRI findings decreased significantly. These results should encourage more women to take this potentially life-saving test."

MRI is playing an increasingly important role in the screening of women at high risk for breast cancer. One drawback of the technology, however, has been a considerable number of breast biopsy procedures recommended on the basis of imaging findings, which turn out to be benign. With MR spectroscopy, the radiologist is able to see the chemical make-up of a tumor, so in most cases, he or she can tell without biopsy whether or not the lesion is cancerous.

"Breast tumors have elevated levels of choline compounds, which are a marker of an active tumor," Dr. Bartella said. "By performing a brief MR spectroscopy procedure after an MRI scan, which takes only 10 additional minutes, we can noninvasively see which tumors show elevated choline levels, and therefore which lesions are likely malignant. This eliminates the need for biopsy to find out what the tumor is made of."

In Dr. Bartella's study, 56 patients with 57 breast lesions underwent MRI first, followed by MR spectrosc
'"/>

Contact: Heather Babiar
hbabiar@rsna.org
630-590-7762
Radiological Society of North America
30-May-2006


Page: 1 2

Related medicine news :

1. High-tech spectroscopy may be used to monitor neuropsychiatric symptoms
2. 1.7m to build worlds first SIMS instrument combined with infra-red spectroscopy
3. MR spectroscopy helps identify cancerous breast tumors
4. MR spectroscopy may be superior for determining prostate cancer prognosis
5. Trial stops after stroke and mortality significantly reduced by blood
6. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
7. Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms
8. Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
9. New study: Pine bark significantly reduces endometriosis
10. Regular acupressure can significantly reduce agitated behavior in dementia
11. Health care expenditures significantly higher for children with obesity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: spectroscopy significantly reduces need for breast biopsy

(Date:9/3/2015)... IN (PRWEB) , ... September 03, 2015 , ... ... Rochester, MN, and Indiana University, Indianapolis, have chosen Center for Hospice Care ... from these institutions will train at CHC as part of fulfilling their requirements ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... in Haiti, has partnered with Slingshot® Product Development Group to manufacture a long-lasting ... water. Michael Wahl with DriButts plans to bring 600 DriButts Diapers to rural ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a comprehensive survey ... and Policy Analysis has found physician leadership development training programs to be growing ... respondents said their organizations conduct some kind of physician leadership development program, another ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado Bellingham, ... and has been carefully designed to serve up to 80 people living with ...
(Date:9/3/2015)... ... September 03, 2015 , ... IQ Formulations today ... by economic development group GrowFL and the Edward Lowe Foundation. The leading health ... this prestigious award, which recognizes growing second-stage companies “that demonstrate high performance in ...
Breaking Medicine News(10 mins):Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3
(Date:9/3/2015)... About dry eye syndrome Dry eye ... deficient tear production or quick tear evaporation or deviation ... aqueous tear deficient dry eye and evaporative dry eye. ... not produce enough tears, whereas meibomian gland dysfunction results ... slow tear evaporation and maintain tear stability. The symptoms ...
(Date:9/3/2015)... , Sept. 3, 2015  WellCare Health Plans, Inc. ... Asher , senior vice president and chief financial officer, ... 2015 Healthcare Conference on Wednesday, September 9, 2015, at ... be webcast live. In addition, a replay of the ... live broadcast. Both the live broadcast and the replay ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. 3, ... a leading global pharmaceutical company, and AqueSys, Inc. ... on developing ocular implants that reduce intraocular pressure ... have entered into an agreement under which Allergan ... the terms of the agreement, Allergan will acquire ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
Cached News: